Fig. 3From: Development of crizotinib-associated renal cyst in a non-small cell lung cancer patient with ALK fusion: a case report and review of the literatureSerial contrast-enhanced abdominal CT scan after discontinuation of crizotinib. Panels A-D: One month after stopping crizotinib treatment, showing significant reduction of the size of cystic lesions. Panels E-H: Two months after stopping crizotinib treatment, showing continuous reduction of the cystic lesions. Panels I-L: Six months after stopping crizotinib treatment, demonstrating size of renal cysts significantly decreased and hepatic cyst nearly disappearedBack to article page